Drug Profile
Tasosartan/hydrochlorothiazide
Latest Information Update: 15 Mar 1999
Price :
$50
*
At a glance
- Originator Wyeth
- Class Benzothiadiazines
- Mechanism of Action Angiotensin type 1 receptor antagonists; Diuretics
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Heart failure; Hypertension
Most Recent Events
- 15 Mar 1999 Discontinued-III for Heart failure in USA (PO)
- 15 Mar 1999 Discontinued-III for Heart failure in World (PO)
- 15 Mar 1999 Discontinued-III for Hypertension in USA (PO)